Press releases
- BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver
- BioLife Solutions Reports First Quarter 2024 Financial Results
- BioLife Solutions to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024
- BioLife Solutions Announces the Divestiture of its Stirling Freezer Business
Key statistics
On Wednesday, BioLife Solutions Inc (BJX1:DUS) closed at 18.40, -11.54% below its 52-week high of 20.80, set on May 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 18.50 |
---|---|
High | 18.60 |
Low | 18.40 |
Bid | 18.40 |
Offer | 18.70 |
Previous close | 18.50 |
Average volume | 11.33 |
---|---|
Shares outstanding | 46.07m |
Free float | 44.71m |
P/E (TTM) | -- |
Market cap | 931.97m USD |
EPS (TTM) | -1.43 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 18:31 BST.
More ▼